• AMPK–JAK2/STAT3 in Obesity-Related Asthma

  2026-09-25

  A study of obesity-related asthma links reduced AMPK expression and M1 macrophage polarization with airway inflammation, and identifies JAK2/STAT3 signaling as a pathway associated with the effects of AMPK activation. Its combined cell and mouse models offer a framework for investigating inflammation inhibition via AMPK activation, while leaving important questions about model specificity and clinical relevance open.

• Carvedilol Phosphate for Mechanistic IRI Studies

  2026-09-25

  Use Carvedilol Phosphate to probe adrenergic GPCR signaling alongside hepatocyte–macrophage interactions in ischemia–reperfusion experiments—not as an assumed treatment for liver injury. This workflow pairs careful compound handling with orthogonal Arrb2, macrophage-polarization, and 6-ketoLCA readouts.

• PYR-41 for E1 Ubiquitination Research

  2026-09-24

  Use PYR-41 to probe ubiquitin activation upstream of protein turnover and inflammatory signaling, with workflows for E1 engagement, NF-κB readouts, and immune-cell studies. Its broad effects make careful dose-ranging and orthogonal controls essential—especially when applying E1 inhibition to the distinct TRAF2–STING biology of tumor-associated B cells.

• Ertapenem: Applied Workflows for Resistance Research

  2026-09-24

  Use Ertapenem sodium salt to connect a reproducible carbapenem susceptibility readout with resistance-gene and transmission analyses. This workflow guide translates recent CREC findings into practical assay choices while emphasizing controls, interpretation limits, and compound handling.

• WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis

  2026-09-23

  The study identifies WNT5a–GSK3–β-catenin signaling as a regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors (FAPs). Its combined pharmacological, cellular, and transcriptomic evidence links pathway modulation to reduced fat infiltration and improved support for muscle satellite-cell differentiation in experimental models.

• EdU Imaging Kits (Cy3): From Signal to Biology

  2026-09-23

  EdU Imaging Kits (Cy3) reveal S-phase DNA synthesis without DNA denaturation. This article shows how to interpret EdU labeling mechanistically in CCR7/DUSP1-regulated fibroblast–tumor models, rather than treating proliferation as an isolated endpoint.

• Meropenem Trihydrate: Mechanism and Resistance Research

  2026-09-22

  Meropenem trihydrate is a broad-spectrum carbapenem antibiotic used to investigate bacterial cell-wall inhibition, antimicrobial susceptibility, and resistance phenotypes. LC-MS/MS evidence shows that metabolite patterns can distinguish carbapenemase-producing Enterobacterales from non-producing isolates in less than 7 hours, but those signatures do not independently prove the resistance mechanism.

• CDK9 inhibitor A3294: Protocol and QC Guide

  2026-09-22

  CDK9 inhibitor A3294 is a selective serine/threonine kinase inhibitor for examining CDK9-dependent transcription elongation, P-TEFb activity, and exploratory HIV-1 propagation inhibition. It is appropriate for controlled biochemical and cell-based research, but not for pan-CDK studies, clinical efficacy claims, or long-term storage of working solutions.

• γH2AX DNA Damage Detection Kit in FLASH-RT

  2026-09-21

  A translational analysis of how γ-H2AX immunofluorescence can connect radiation-induced DNA damage with radiosensitization, apoptosis, immune remodeling, and preclinical decision-making.

• Trelagliptin, PI-3K/AKT, and Adipocyte Insulin Resistance

  2026-09-21

  The reference study investigates how trelagliptin succinate affects insulin resistance in differentiated 3T3-L1 adipocytes, linking DPP-4 inhibition with PI-3K/AKT signaling, GLUT4 membrane localization, glucose intake, and adipokine secretion. Its main practical contribution is a mechanistic cell-based framework for evaluating insulin-sensitizing effects while highlighting the need for careful phosphorylation-state analysis.

• Native Protein Gel Electrophoresis: K4142 Guide

  2026-09-20

  A scenario-based guide to native protein gel electrophoresis for researchers interpreting cell viability, proliferation, and cytotoxicity data. It explains how Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0), SKU K4142, supports native-state protein analysis, workflow control, and practical vendor selection.

• RQ3025 Bivalent mRNA Vaccine: Preclinical Evidence

  2026-09-19

  The RQ3025 candidate uses a mutation-informed bivalent mRNA design to broaden neutralizing activity against SARS-CoV-2 variants. Across mice, hamsters, and rats, the study found broad antibody responses, variant protection in vaccinated rats, a Th1-biased cellular profile, and no observed organ pathology after high-dose administration.

• From S-Phase Signal to Tumor Relapse Insight

  2026-09-18

  A translational framework for using EdU-based S-phase measurements to distinguish actively replicating tumor cells from low-cycling relapse reservoirs, with practical guidance for microscopy, flow cytometry, genotoxicity assessment, and pharmacodynamic study design.

• Propranolol Workflows for Translational Research

  2026-09-18

  Build reproducible Propranolol experiments across cardiovascular regulation, emotional memory modulation, essential tremor research, and metabolic assays. This guide combines formulation, dose-screening, TMS-informed endpoint selection, and troubleshooting for a non-selective β-adrenergic receptor blocker.

• AMG 9810: Translational Control of TRPV1

  2026-09-17

  AMG 9810 offers a precise pharmacological lens for separating TRPV1-driven sensory signaling from broader metabolic and oxidative stress responses. This thought-leadership guide connects TRPV1 assay design with emerging insights into AMPK, SQSTM1/p62, lysosomal stress, and translational research strategy while clearly distinguishing established evidence from testable hypotheses.

8097 records 1/540 page Next 12345 下5页 Last page